Skip to content

Smartphone cognitive behavioral therapy for social anxiety in adolescences

Smartphone-Based Cognitive Behavioral Therapy for Subthreshold Social Anxiety in Adolescences: A Multi-center Randomized Controlled Trial - Smartphone-Based Cognitive Behavioral Therapy for Subthreshold Social Anxiety in Adolescences: Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050064
Enrollment
78
Registered
2023-01-27
Start date
2023-01-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subthreshold Social Anxiety

Interventions

Smartphone-App education baed on cognitive behavioral therapy No tretment

Sponsors

Kagoshima University
Lead Sponsor
University of Fukui, Chiba University, Naruto University of Education, Shigakukan University, Fukusima Gakuin University, Jinai University, Kochi Kokusai High School
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who meet all of the following criteria Have sub-threshold social anxiety (LSAS total score > 30 points). User of his/her smartphone on a daily basis. 15 to 25 years old. Adolecenses and young adults enrolled high school, university, vocational school, etc.

Exclusion criteria

Exclusion criteria: Meet diagnostic criteria for social anxiety disorder on DSM-5. Conducted cognitive-behavioral therapy for social anxiety within 2 years. IQ < 85. Mental disorders such as major depressive disorder. High risk of suicide. Progressive disease such as cancer.

Design outcomes

Primary

MeasureTime frame
Mean differences in the total Leibovitz Social Anxiety Scale from baseline to post-intervention (10 weeks after intervention start).

Secondary

MeasureTime frame
The secondary outcomes are changes in scales for measuring clinical symptoms and quality of life (QOL): Liebowitz Social Anxiety Scale, LSAS; Social Phobia Inventory, SPIN; Patient Health Quesitonnire-9, PHQ-9; Generalized Anxiety Disorder Quesitonnire-7, GAD-7; EuroQol 5 Dimensions 5-Level, EQ-5D-5L.

Countries

Japan

Contacts

Public ContactKazuki Matsumoto

Kagoshima University Hospital Division of Clinical Psychology

k2782199@kadai.jp099-275-5707

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026